All other analyzed parameters such as sex, age, tumor type, hepatic tumor burden, previous therapies or lab parameters such as international normalized ratio (INR), ALT, AST and gamma-glutamyltransferase (yGT) had no predictive value for not performing TARE after 99mTc-MAA evaluation. The gene discussed is GPT; the disease is neoplasm.